Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$57M
1 round on record
Latest round
$57M
Venture round · Mar 2018 · 8 yr ago
Backers
2
EcoR1 Capital, Pontifax
The money's age
Long since its last round
103 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 7, 2018 Raised a round Venture round $57M · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2018 $57M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Prevail Therapeutics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Asa AbeliovichExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

People

Asa Abeliovich
Executive Officer, Director
Peter Thompson
Director
Mona Ashiya
Director
Carl Gordon
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York United States
HQ

Financials

Total raised
$57M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2018 $57M Details